Compared with insulin alone, oral antidiabetic drugs alone or in addition to insulin were associated with reduced fracture risks among patients with type 2 diabetes. Oral antidiabetic drugs (OADs) are ...

What about in the real word, far away from the ideal conditions of randomized trials? Could combining SGLT2 inhibitors with GLP-1R agonists be even more effective? These are the questions answered by ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors may surpass other oral antidiabetic drugs in metabolic dysfunction–associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In adults with ...

(HealthDay News) — For patients with type 2 diabetes, not delaying intensification of oral antidiabetic drugs (OADs) is associated with greater reductions in hemoglobin A1c (HbA1c), and with reduced ...

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs. Objectives: Medication ...

Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer ...

Abbott and MSD Pharmaceuticals on Wednesday announced a partnership for distribution of oral anti-diabetic medicines in India. Under a distribution agreement, Abbott will distribute the oral ...